Brain Tumors

Tumors that originate in the brain are a relatively rare form of cancer, with only about 22,500 new cases diagnosed in the United States each year. The outlook for these patients is not good because most types of brain tumors are malignant and difficult to fully remove. Brain tumors account for only 1.4% of all cancers, but 2.4% of all cancer-related deaths. The American Cancer Society estimates that about 13,000 people will die this year from malignant brain tumors.


Information from the PET/CT scan helps physicians characterize brain tumors and guide biopsy.


Treatment can be tailored specifically to the patient, depending upon the location and extent of cancer.


Information from the PET/CT scan allows physicians to monitor recurrent disease.

PET/CT Utilization and Case Studies

PET/CT is a noninvasive test that physicians utilize to stage the entire body for the presence or absence of active tumor, localize the tumor, assess the tumor response to treatment and detect recurrence in treated lesions.

Source: American Cancer Society. Cancer Facts & Figures 2011. Atlanta: American Cancer Society; 2011